Evidence map›Paper›PMID 31942194›Full record

ArticleJournal of Cancer2020

Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells.

Michael Gorry, Toshie Yoneyama, Lazar Vujanovic, Marcia L Moss, Michelle A Garlin, Miles A Miller, James Herman, Laura P Stabile, Nikola L Vujanovic

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Michael GorryUniversity of Pittsburgh Cancer Institute, Pittsburgh, PA.
Toshie YoneyamaUniversity of Pittsburgh Cancer Institute, Pittsburgh, PA.
Lazar VujanovicUniversity of Pittsburgh Cancer Institute, Pittsburgh, PA.
Marcia L MossBioZyme Inc, Apex, NC.
Michelle A GarlinCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Miles A MillerCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
James HermanUniversity of Pittsburgh Cancer Institute, Pittsburgh, PA.
Laura P StabileUniversity of Pittsburgh Cancer Institute, Pittsburgh, PA.
Nikola L VujanovicUniversity of Pittsburgh Cancer Institute, Pittsburgh, PA.
University of Pittsburgh · USMassachusetts General Hospital · USBioZyme (United States) · USUPMC Hillman Cancer Center · USVA Pittsburgh Healthcare System · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Vitamin D3 Modulation of Inflammation and Lung Cancer RiskP50CA090440 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIEGFRIED, JILL M · 2001 to 2015
$34.6M
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA090440
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADAM10.AssaysCell membraneEnzyme activityFlow cytometrySingle cell

Identifiers

PMID31942194
PMCPMC6959049
OpenAlexW3006823652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.